As free trade reaches a crossroads in the US, developing countries have to rethink their own trade realities for their own development interests. “Free trade” seems to be in deep trouble in the United States, with serious implications for the rest of the world. Opposition to free trade or trade agreements emerged as a big theme among the leading American presidential candidates. (more…)
The Rise of Investor-State Dispute Settlement in the Extractive Sectors: Challenges and Considerations for African Countries
African countries have been active in concluding international investment treaties. They are increasingly subject to investor-state dispute settlement (ISDS) cases, including claims that challenge regulatory actions of host countries in a wide range of areas, including public services and race relations. At the same time, African States have developed the ‘Africa Mining Vision’, which is aimed at introducing policy (more…)
WTO’s MC10: The Call for ‘New Issues’ at the WTO and Implications for Developing Countries
Narratives concerning enhancing the participation of developing countries in ‘Global Value Chains’ (GVCs) and supporting micro, small and medium enterprises have featured prominently in the WTO
and other international organizations. These have intensified in the run up towards the Ministerial Conference in Nairobi. These discourses on GVCs and MSMEs have often been linked to (more…)
When launched in 2001, the Doha Development Agenda (DDA) had the objective of being a Development Round. However, substantive development concerns have often been sidelined in the course of the negotiations. Without the Doha mandate, developing countries have no guarantee that the important issues of disciplines on domestic supports, special safeguard in agriculture and cotton will feature in future negotiations on Agriculture. (more…)
WTO’s MC10: Agriculture Negotiations– Public Stockholding
Public stockholding programmes have over the past decades proven themselves to be very effective instruments for supporting domestic producers in agricultural production. Studies have shown that in
fact, countries that are still in the process of development, where markets are not well developed, need such public stockholding programmes to support their farmers.
Many developing countries do have these programmes. This non-exhaustive list (more…)
WTO’s MC10: Agriculture Negotiations – Special Safeguard in Agriculture for Developing Countries
The agricultural safeguard is important for developing countries. Most developed countries already have access to a special agricultural safeguard as a result of the Uruguay Round negotiations, and
some of them have actively utilised this Special Safeguard Provisions (SSG) through the past 20 years.
Developing countries require a similar instrument because of the many agricultural import surges taking place. (more…)
This note provides a brief on Export Competition and the four issues that it covers:
With respect to export subsidies, the EU, the Member with the largest export subsidy entitlements applies zero export subsidies under its Common Agricultural Policy 2014-2020. Commitments to bind export subsidies at zero are therefore a step in the right direction but the extent of its value is limited. The Green Box remains undisciplined (more…)
Guidelines on Patentability and Access to Medicines
The important relationship between the examination of patents carried out by national patent offices and the right of citizens to access to medicines hasn’t always been well-understood. Too often these are viewed as to unrelated functions or responsibilities of the State . And the reason is clear: Patentability requirements are not defined by patent offices, but frequently by the courts, tribunals, legislation or treaty negotiators. (more…)
South Centre Calls on the WTO TRIPS Council to Support Access to Medicines and Technological Advancement for the Least Developed Countries
The South Centre fully supports the Least Developed Countries’ (LDC) request for an extension of the transition period granted to LDCs under Article 66.1 of the World Trade Organization’s Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) in respect of pharmaceutical products for as long as a WTO member remains an LDC, and the waiver from obligations under Articles 70.8 and 70.9 of the TRIPS Agreement. (more…)
Foreign Direct Investment, Investment Agreements and Economic Development: Myths and Realities
Foreign direct investment (FDI) is one of the most ambiguous and the least understood concepts in international economics. Common debate on FDI is confounded by several myths regarding its nature and impact on capital accumulation, technological progress, industrialization and growth. It is often portrayed as a long term, stable, cross-border flow of capital that adds to productive capacity, helps meet balance-of-payments shortfalls, transfers technology and management skills, and links domestic firms with wider global markets. However, none of these are intrinsic qualities of FDI. (more…)
Intellectual Property in the Trans-Pacific Partnership: Increasing the Barriers for the Access to Affordable Medicines
Most free trade agreements signed by the United States, the European Union and the members of the European Free Trade Association (EFTA) in the last 15 years contain chapters on intellectual property rights with provisions applicable to pharmaceuticals. Such provisions considerably expand the rights recognized to pharmaceutical companies under the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) established in the context of the World Trade Organization. (more…)
Ecuador’s Experience with International Investment Arbitration
The brief reviews Ecuador’s experience with investment treaties and investor-state dispute settlement (ISDS). The paper explains the historical and geopolitical context of the decisions Ecuador has taken in regard to bilateral investment treaties (BITs) and ISDS. The author notes that a number of treaties did not fulfill the constitutional and legal ratification processes. (more…)